Stock Price Movement and Market Context
On 13 Mar 2026, Shree Ganesh Biotech India Ltd’s share price declined by 1.72% to reach Rs.0.55, the lowest level recorded in the past year and since its listing. This new low comes despite the stock outperforming its sector by 4.67% on the day, as the Pharmaceuticals & Biotechnology sector faced downward pressure. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend.
The broader market environment has also been challenging. The Nifty index closed at 23,151.10, down 488.05 points or 2.06%, with multiple indices such as NIFTY MEDIA, NIFTY REALTY, and S&P Bse Dollex 30 hitting their own 52-week lows. Mid-cap stocks, in particular, dragged the market lower, with the Nifty Midcap 100 index falling 2.65%. The Agriculture sector, related to the company’s industry context, declined by 6.5%, adding to the negative sentiment.
Financial Performance and Fundamental Metrics
Over the past year, Shree Ganesh Biotech India Ltd’s stock has depreciated by 41.24%, a stark contrast to the Sensex’s modest 1.00% gain over the same period. The company’s 52-week high was Rs.1, highlighting the extent of the decline.
The company’s financial fundamentals remain under pressure. It has reported operating losses, which contribute to a weak long-term fundamental strength assessment. The average EBIT to interest coverage ratio stands at 0.82, indicating limited capacity to comfortably service debt obligations. Additionally, the average return on equity (ROE) is 2.62%, reflecting low profitability relative to shareholders’ funds.
Recent financial results for the half-year ended December 2025 were largely flat, with a notably low debtors turnover ratio of 0.00 times, suggesting challenges in receivables management. The company’s EBITDA remains negative, further underscoring the financial strain.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Shareholding and Valuation Considerations
The majority of Shree Ganesh Biotech India Ltd’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The stock is classified as a micro-cap, reflecting its relatively small market capitalisation and associated volatility.
Valuation metrics indicate the stock is trading at levels considered risky compared to its historical averages. Profitability has deteriorated sharply, with profits falling by 115.5% over the past year, reinforcing the cautious stance reflected in its MarketsMOJO Mojo Grade, which was downgraded from Sell to Strong Sell on 8 Aug 2024. The current Mojo Score stands at 12.0, signalling significant concerns regarding the company’s financial health and outlook.
Technical Indicators
Technical analysis presents a mixed picture. On a weekly basis, the MACD and KST indicators show mild bullish signals, while the monthly outlook for these indicators is bearish. The Relative Strength Index (RSI) is neutral on a weekly scale but bullish monthly. Bollinger Bands and Dow Theory readings are bearish on both weekly and monthly timeframes. Daily moving averages also indicate a bearish trend, consistent with the stock’s recent price action.
Is Shree Ganesh Biotech India Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Key Concerns
The stock’s fall to Rs.0.55 marks a significant milestone in its downward trajectory, reflecting a combination of weak financial performance, low profitability, and challenging market conditions. The company’s inability to generate positive EBITDA and its limited capacity to service debt have contributed to the cautious market sentiment. Technical indicators largely support the current bearish trend, although some weekly signals show mild bullishness.
Despite outperforming its sector on the day of the new low, the broader Pharmaceuticals & Biotechnology sector and related industries have experienced declines, compounding the pressures on Shree Ganesh Biotech India Ltd’s share price. The micro-cap status and non-institutional majority shareholding add layers of complexity to the stock’s trading dynamics.
Overall, the stock’s performance over the past year, combined with its fundamental and technical indicators, underscores the challenges faced by Shree Ganesh Biotech India Ltd in the current market environment.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
